Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Its only for premenopausal women with no history of heart disease
Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, Deng C, Fan C, Di S, Sun Y, et al
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
Food & Drug Administration (FDA) Wegovy (Semaglutide) Prescribing Information: National Library of Medicine Insulin Syringes:
tirzepatide out-loses semaglutide even at lower dose intensity (le Roux Journal of Endocrinological Investigation 2026)
US$ 26.98
US$ 28.92
US$ 23.80
US$ 26.63
US$ 28.27
US$ 24.22
US$ 26.10
US$ 24.20
US$ 22.78
US$ 25.59
US$ 23.94
US$ 23.01
US$ 20.70
US$ 24.83
US$ 23.83
US$ 23.17
